| Recruiting | Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency Type II Diabetes Mellitus | Phase 1 | 2026-02-25 |
| Recruiting | Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus Type II Diabetes Mellitus | Phase 2 | 2026-01-20 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Moderate to Severe Genital Psoriasis | Phase 3 | 2025-03-21 |
| Active Not Recruiting | A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Crea Acne Vulgaris | Phase 4 | 2024-07-01 |
| Completed | A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients Acne Vulgaris | Phase 4 | 2024-02-29 |
| Completed | A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients Acne Vulgaris | Phase 4 | 2023-11-27 |
| Completed | A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Perox Acne Vulgaris | Phase 4 | 2023-11-15 |
| Completed | A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment o Acne Vulgaris | Phase 4 | 2023-11-15 |
| Completed | A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne Acne Vulgaris | Phase 4 | 2023-09-01 |
| Active Not Recruiting | Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis Psoriatic Arthritis | Phase 3 | 2022-06-30 |
| Completed | A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension Primary Open Angle Glaucoma, Ocular Hypertension | Phase 3 | 2021-12-20 |
| Completed | To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis Dermatitis, Atopic | Phase 2 | 2021-07-30 |
| Completed | Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis Chronic Plaque Psoriasis, Moderate to Severe Nail Psoriasis | Phase 3 | 2021-05-13 |
| Completed | To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis Moderate to Severe Plaque Psoriasis | Phase 2 | 2021-03-25 |
| Completed | Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis Osteoarthritis of Knee | Phase 2 | 2020-12-22 |
| Completed | Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIR Active Psoriatic Arthritis | Phase 3 | 2020-07-01 |
| Active Not Recruiting | Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arth Active Psoriatic Arthritis | Phase 3 | 2020-07-01 |
| Completed | Effect of Cequa™ in Subjects With Dry Eye Disease Dry Eye Disease | Phase 4 | 2020-06-29 |
| Active Not Recruiting | A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis Moderate-to-severe Chronic Plaque Psoriasis | Phase 2 / Phase 3 | 2020-01-15 |
| Recruiting | Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab Pregnancy Related | — | 2019-08-29 |
| Completed | A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis Psoriasis | Phase 4 | 2019-07-16 |
| Withdrawn | A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular H Open Angle Glaucoma, Ocular Hypertension | Phase 3 | 2019-06-10 |
| Completed | Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis Scalp Psoriasis | Phase 3 | 2019-03-29 |
| Completed | Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Ca Basal Cell Carcinoma | — | 2019-03-11 |
| Completed | A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Asthma | Phase 3 | 2018-09-22 |
| Completed | Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have P Psoriatic Arthritis | Phase 2 / Phase 3 | 2018-07-11 |
| Completed | Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects Active, Symptomatic Blepharitis | Phase 3 | 2018-03-30 |
| Completed | Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Inflammation and Pain Associated With Cataract Surgery | Phase 3 | 2018-01-30 |
| Completed | 2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Catarac Inflammation and Pain Associated With Cataract Surgery | Phase 3 | 2018-01-03 |
| Withdrawn | A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease Dry Eye Disease | Phase 2 | 2018-01-01 |
| Terminated | Efficacy and Safety Study of SUNPG1622 Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis | Phase 2 | 2017-11-06 |
| Terminated | Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spra Atopic Dermatitis | Phase 2 | 2017-07-24 |
| Completed | Efficacy and Safety Study of SUNPG1623 Active Psoriatic Arthritis | Phase 2 | 2017-04-19 |
| Terminated | Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05% Plaque Psoriasis | Phase 4 | 2017-03-21 |
| Withdrawn | Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spra Plaque Psoriasis | Phase 2 | 2017-01-01 |
| Completed | One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With Metastatic Prostate Cancer | Phase 2 | 2016-11-01 |
| Completed | An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca Keratoconjunctivitis Sicca | Phase 3 | 2016-07-29 |
| Completed | A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer Prostate Cancer | Phase 2 | 2016-03-21 |
| Completed | Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca Keratoconjunctivitis Sicca | Phase 3 | 2016-02-01 |
| Terminated | To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheum Active Rheumatoid Arthritis | Phase 3 | 2015-11-01 |
| Completed | ABSORICA in Patients With Severe Recalcitrant Nodular Acne Acne | Phase 4 | 2015-01-21 |
| Completed | Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Si Keratoconjunctivitis Sicca, Dry Eye Disease | Phase 2 / Phase 3 | 2014-09-01 |
| Withdrawn | A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate Plaque-type Psoriasis | Phase 3 | 2013-09-01 |
| Completed | Bio-equivalence Study Between SAPHRIS and Asenapine Schizophrenia, Bipolar Disorder | Phase 1 | 2013-07-01 |
| Completed | Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects Ocular Inflammation | Phase 3 | 2013-05-01 |
| Completed | Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 3 | 2013-03-01 |
| Completed | A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Plaque Psoriasis | Phase 3 | 2013-02-05 |
| Completed | A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Plaque Psoriasis | Phase 3 | 2012-12-06 |
| Terminated | Efficacy and Safety Of Spil's Estradiol Vaginal Tablet Vulvar Atrophy, Vaginal Atrophy | Phase 3 | 2012-11-06 |
| Completed | Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects Ocular Inflammation | Phase 3 | 2012-07-01 |
| Completed | Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis Blepharitis | Phase 3 | 2011-10-01 |
| Completed | Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prio Cataract | Phase 2 | 2011-07-01 |
| Completed | Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Ca Ocular Inflammation | Phase 1 / Phase 2 | 2010-08-01 |
| Completed | Pharmacokinetic and Pharmacodynamic Study of Cyclofem Contraception | Phase 1 / Phase 2 | 2010-06-01 |
| Completed | Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Ble Blepharoconjunctivitis | Phase 3 | 2007-12-01 |
| Completed | Letrozole vs. Clomiphene Citrate in Patients With Anovulatory Infertility Infertility | Phase 3 | 2004-12-01 |
| Withdrawn | Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine Oral Mucositis, Stomatitis | Phase 4 | — |
| Withdrawn | Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Ble Blepharoconjunctivitis | Phase 3 | — |